Research programme: cancer therapy adjuvants - VG Life Sciences

Drug Profile

Research programme: cancer therapy adjuvants - VG Life Sciences

Alternative Names: 2-deoxyglucose/etomoxir - MetaCytoLytics; Dichloroacetic acid - MetaCytoLytics; MDT compounds - MetaCytoLytics

Latest Information Update: 04 Nov 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator University of Colorado Foundation; University of Vermont
  • Developer VG Life Sciences
  • Class Acetates; Deoxy sugars; Epoxy compounds
  • Mechanism of Action Antimetabolites; Carnitine O-palmitoyltransferase inhibitors; Enzyme inhibitors; Glucose modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Solid tumours

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for preclinical development in Solid-tumours(Late-stage disease, Adjuvant therapy) in USA
  • 30 Nov 2012 Viral Genetics is now called VG Life Sciences
  • 23 May 2012 Viral Genetics plans a clinical trial for Ovarian cancer (adjuvant therapy, late-stage disease) in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top